To conclude, in addition to lifestyle changes, such as physical activity and dietary modifications as important adjuncts to pharmacotherapy in managing NAFLD, GLP1-RAs demonstrated the highly efficient modulation and alleviation of hepatic steatosis and aberrant signaling pathways involved in NAFLD pathophysiology and progression in vitro. The gene discussed is GCG; the disease is fatty liver disease.